Using artificial intelligence to predict ischemic cerebrovascular disease early

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This project aims to develop an artificial intelligence-based clinical decision support system to identify patients with carotid and vertebral artery stenosis who are at risk of cerebral infarction. By analyzing demographic and clinical data from multiple centers, the study seeks to create a predictive model for disease progression and adverse cardiovascular events. The goal is to enhance secondary prevention strategies for chronic stroke management, ultimately improving patient outcomes and reducing healthcare costs associated with ischemic stroke.

Why it matters

Who can join: the full rules

Inclusion Criteria:

Patients undergoing vascular (carotid/vertebral artery) B-ultrasound

Exclusion Criteria:

Patients with missing clinical data such as medical history, cerebrovascular ultrasound results and biochemical data

Where it's running

• Model
  Shanghai, Shanghai Municipality, China Recruiting

Study contacts

• Principal investigator: Yijun Cheng, Doc — Ruijin Hospital
• Study coordinator: Yijun Cheng, Doc
• Email: cyj12574@rjh.com.cn
• Phone: 86+15021058538

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• AI-assisted prehabilitation to help oral cancer patients return to work

  This trial will test an AI-assisted prehabilitation program to help adults with oral cancer reduce physical and emotional problems and return to work.

  Recruiting at 4 sites Taipei Veterans General Hospital, Taiwan · Taipei and 4 other locations · NCT07562100

• Predicting pregnancy risks for women with aplastic anemia

  This project will try to create a model to predict which pregnant women with aplastic anemia are most likely to have maternal or newborn complications.

  Recruiting Peking University People's Hospital · Beijing · NCT07101770

• New biomarkers for ischemic cerebrovascular disease

  This study will test whether specific blood, cerebrospinal fluid, urine, and stool biomarkers can help diagnose and predict outcomes for people with ischemic stroke and related cerebrovascular conditions.

  Recruiting Tongji Hospital · Wuhan, Hubei and 1 other locations · NCT06890702

• Evaluating the effects of Calculus Bovis Sativus for ischemic cerebrovascular diseases

  This study is testing whether a traditional Chinese medicine called Calculus Bovis Sativus can help improve brain health and reduce inflammation in people with ischemic cerebrovascular diseases like stroke.

  Recruiting at 2 sites Tongji Hospital · Wuhan, Hubei and 1 other locations · NCT06474507

• Predicting brain swelling after stroke treatment

  This study is testing a new way to predict which stroke patients are at risk for dangerous brain swelling after a specific treatment to help doctors make better decisions for their care.

  Recruiting Zhejiang Provincial People's Hospital · Hangzhou, Zhejiang · NCT06451887

• Prognosis prediction for patients with cardiovascular and cerebrovascular diseases using multi-omics

  This study is trying to find out how different biological factors affect people with heart and brain blood vessel diseases to help doctors predict outcomes and personalize treatments for them.

  Recruiting First Affiliated Hospital Xi'an Jiaotong University · Xi'an, Shaanxi · NCT06001073

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.